Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Chemours Company (The) (CC)

NYSE: CC · Chemicals & Allied Products · Wilmington, DE

Our rating: Cautious

Cautious reaffirmed at $21.77, moderate conviction, June 18, 2026.

Breaks if: The Cautious call is wrong if Chemours generates free cash flow above $120M in any single fiscal half-year in the next twelve months, or if reported net income turns positive for a full fiscal year — either outcome would indicate the loss is non-recurring and the cash engine is genuinely rebuilding.

Key figures

Market value$1.6B
Revenue, last 12 months$5.8B
Net income, last 12 months−$154M
Free cash flow, last 12 months$211M
Price to earningsn/a
Free cash flow yield12.9%
Dividend yield3.2%
Operating marginn/a
Return on equity−71.8%
Beta to the S&P 5001.78
Volatility, annualized60.2%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$1.5B3.0%$1.29$98M
June 30, 2026$1.6B−1.5%$-1.81$114M
March 31, 2026$1.4B1.0%$-0.19−$93M
December 31, 2025$1.3B−2.2%$-0.31$92M
September 30, 2025$1.5B−0.9%$0.31$105M
June 30, 2025$1.6B3.9%$-2.53$50M
March 31, 2025$1.4B0.4%$-0.03−$196M
December 31, 2024$1.4B−0.7%$-0.08$29M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

8 ledger entries and 76 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.